Disclaimer: TheDailyGold.com and TheDailyGold Premium are not investment advice. The website, email newsletter and premium newsletter are intended only for informational, educational and research purposes only.
The information, facts, figures, data and analysis included in our publications are believed to be accurate, reliable and credible but nothing has been independently verified for its certainty. Also, facts, figures and data can change at any moment, thereby affecting past analysis and conclusions. The newsletter and website are not tailored to anyone’s financial situation and therefore do not, nor could they; take into account the needs, objectives and financial situation of its readers and subscribers. Readers are strongly encouraged to consult with a qualified financial advisor before making any financial decisions.
"Better then gold." $CEMI. Chembio Diagnostics Substantially undervalued.
F.D.A. approval on its Covid/Flu test could happen at any time which will double/triple the share price. Last time it received approval on one of its tests, it traded over 600,000,000 shares in two days and hit $7.12 because the shorts had oversold it. Potential takeover target at $15+. Buy a few shares on before the next p.r.
"Better then gold." $CEMI. Chembio Diagnostics Substantially undervalued.
F.D.A. approval on its Covid/Flu test could happen at any time which will double/triple the share price. Last time it received approval on one of its tests, it traded over 600,000,000 shares in two days and hit $7.12 because the shorts had oversold it. Potential takeover target at $15+. Buy a few shares on before the next p.r.